CONTE, PIETRO
 Distribuzione geografica
Continente #
NA - Nord America 167
EU - Europa 56
AS - Asia 44
SA - Sud America 9
AF - Africa 1
Totale 277
Nazione #
US - Stati Uniti d'America 167
SG - Singapore 23
FI - Finlandia 20
IT - Italia 14
BR - Brasile 8
CN - Cina 8
HK - Hong Kong 8
UA - Ucraina 6
DE - Germania 5
GB - Regno Unito 3
BG - Bulgaria 2
IE - Irlanda 2
KR - Corea 2
PL - Polonia 2
AR - Argentina 1
CI - Costa d'Avorio 1
IL - Israele 1
RU - Federazione Russa 1
SE - Svezia 1
TR - Turchia 1
TW - Taiwan 1
Totale 277
Città #
Fairfield 22
Seattle 19
Woodbridge 19
Helsinki 18
Ashburn 15
Singapore 14
Houston 12
Cambridge 11
Wilmington 10
Hong Kong 8
Jacksonville 8
Trieste 6
Ann Arbor 5
Chandler 5
Boardman 4
Princeton 4
Buffalo 3
San Jose 3
São Paulo 3
Columbus 2
Dublin 2
Falls Church 2
Heidelberg 2
Lavis 2
Nanjing 2
Norwalk 2
Nuremberg 2
Pignone 2
Sofia 2
Zgierz 2
Abidjan 1
Altinópolis 1
Brejo 1
Cuiabá 1
Dallas 1
Des Moines 1
Diadema 1
Fortaleza 1
Izmir 1
Los Angeles 1
Manchester 1
Milan 1
Moscow 1
New York 1
Orem 1
Ramos Mejía 1
Redwood City 1
Rome 1
San Diego 1
Simi Valley 1
Taipei 1
Tel Aviv 1
Totale 233
Nome #
Safety of everolimus plus exemestane in patients with hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: Primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET) 163
Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-Positive breast cancer patients treated with chemotherapy and HER2-Targeted agents in the CherLOB trial 122
Totale 285
Categoria #
all - tutte 1.042
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.042


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202115 0 0 0 0 0 0 0 3 4 4 0 4
2021/202223 0 2 0 0 1 4 2 1 5 3 2 3
2022/202318 2 0 1 1 4 4 0 3 0 0 2 1
2023/202415 0 3 0 0 0 2 0 5 0 2 1 2
2024/202535 0 2 2 2 2 9 0 8 2 2 4 2
2025/202645 4 1 4 2 8 10 16 0 0 0 0 0
Totale 285